EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK - Teal Health announced on Friday that its self-collection device for human papillomavirus testing has obtained US Food and Drug Administration approval. The device can be used to collect ...

Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...

Congress has passed delays to PAMA implementation, but such a pause could be less likely this year, warn industry stakeholders.

The firm filed for Chapter 11 protection on Thursday and is seeking to sell its assets after facing turmoil in recent years.

The agreement enables rapid diagnostic test manufacturing in the Africa region and will initially focus on HIV testing.

Note: This story has been updated with comments from a conference call to discuss the firm's financial results. NEW YORK – Siemens Healthineers said Wednesday that it expects tariffs implemented by ...

The money will support the development of the firm's PidPort system for storage, viewing, sharing, and analysis of digital images of pathology slides.